Effectiveness of screening for tuberculosis in HIV: a pragmatic clinical trial

Autores

DOI:

https://doi.org/10.11606/s1518-8787.2021055002936

Palavras-chave:

HIV Infections, Tuberculosis, diagnosis, Mass Screening, Clinical Trial

Resumo

OBJECTIVE: To verify the effectiveness of screening for tuberculosis (TB) on all-cause mortality and tuberculosis cases in newly diagnosed HIV-infected patients through a clinical algorithm based on recommendations of the World Health Organization. METHODS: From March 2014 to April 2016, a pragmatic randomized clinical trial was conducted with newly diagnosed and TB-free HIV-infected adults undergoing antiretroviral therapy for up to one month at a major tertiary hospital for HIV in the state of Pernambuco, Brazil. Participants were randomized into intervention and control groups using an automatically-generated random list, and followed-up for at least 6 months. The intervention group was screened for TB at hospital admission and at every follow-up visit through a series of questions addressing TB-related symptoms (cough, fever, night sweating, and weight loss). Patients presenting with any of these symptoms were referred to a pulmonologist and underwent sputum smear microscopy, sputum culture, and rapid molecular testing (GeneXpert). When at least one test result came back positive, TB treatment was initiated. In turn, if patients tested negative but presented with severe clinal symptoms, TB preventive treatment was initiated. Screening for TB was not performed systematically in the control group. The primary outcome assessed in this study was death from all causes, and secondary outcomes included sensitivity and specificity of this screening test, as well as its detection time. RESULTS: This study evaluated 581 patients, 377 in the intervention group (64.9%) and 204 in the control group (35.1%). In total, 36 patients died during the follow-up period. Of these, 26 (6.9%) were from the intervention group, reaching a cumulative mortality coefficient of 69 per 1,000 inhabitants, and 10 (4.9%) from the control group (p = 0.341), with a cumulative mortality coefficient of 49 per 1,000 inhabitants (p = 0.341).

Referências

Albuquerque MFPM, Coimbra I, Batista JD, Maruza M, Ximenes RAA, Lacerda HR, et al. Empirical treatment for TB in HIV: lessons from a cohort study of people living with HIV treated in Recife, Brazil. BMC Public Health. 2014;14:289. https://doi.org/10.1186/1471-2458-14-289 [ Links ]

Coimbra I, Maruza M, Militão-Albuquerque MFP, Moura LV, Diniz GTN, Miranda-Filho D B, et al. Associated factors for treatment delay in pulmonary tuberculosis in HIV-infected individuals: a nested case-control study. BMC Infect Dis. 2012;12:208. https://doi.org/10.1186/1471-2334-12-208 [ Links ]

World Health Organization. Global tuberculosis report 2016. Geneva (CH): WHO; 2016 [cited 2017 Oct 25]. Available from: http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1 [ Links ]

Sousa Filho MP, Luna IT, Silva KL, Pinheiro PNC. Pacientes vivendo com HIV/AIDS e coinfecção tuberculose: dificuldades associadas à adesão ou ao abandono do tratamento. Rev Gaucha Enferm. 2012;33(2):139-45. https://doi.org/10.1590/S1983-14472012000200020 [ Links ]

UNAIDS. Vivendo com HIV mas morrendo de tuberculose. Brasília, DF: UNAIDS Brasil; 2017 [cited 2017 Nov 8; posted 2017 Nov 3]. Available from: http://unaids.org.br/2017/11/vivendo-com-hiv-mas-morrendo-de-tuberculose/#more-7621 [ Links ]

Uplekar M, Creswell J, Ottmani SEO, Weil D, Sahu S, Lönnroth K. Programmatic approaches to screening for active tuberculosis. Int J Tuberc Lung Dis. 2013;17(10):1248-56. https://doi.org/10.5588/ijtld.13.0199 [ Links ]

Lönnroth K, Corbett E, Golub J, Godfrey-Faussett P, Uplekar M, Weil D, et al. Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis. 2013;17(3):289-98. https://doi.org/10.5588/ijtld.12.0797 [ Links ]

World Health Organization. Global tuberculosis control report 2011. Geneva (CH): WHO; 2011 [cited 2017 Nov 14]. Available from: https://apps.who.int/iris/handle/10665/44728 [ Links ]

Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8(1):e1000391. https://doi.org/10.1371/journal.pmed.1000391 [ Links ]

Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, et al. Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis. BMC Pulm Med. 2016;16(1):147. https://doi.org/10.1186/s12890-016-0316-z [ Links ]

Floridia M, Ciccacci F, Andreotti M, Hassane A, Sidumo Z, Magid NA, et al. Tuberculosis case finding with combined rapid point-of-care assays (Xpert MTB/RIF and Determine TB LAM) in HIV-positive individuals starting antiretroviral therapy in Mozambique. Clin Infect Dis. 2017;65(11):1878-83. https://doi.org/10.1093/cid/cix641 [ Links ]

Kakinda M, Matovu JKB, Obuku EA. A comparison of the yield of three tuberculosis screening modalities among people living with HIV: a retrospective quasi-experiemental study. BMC Public Health. 2016;16(1):1080. https://doi.org/10.1186/s12889-016-3763-9 [ Links ]

Khan FA, Verkuijl S, Parrish A, Chikwava F, Ntumy R, El-Sadr W, et al. Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped. AIDS. 2014;28(10):1463-72. https://doi.org/10.1097/QAD.0000000000000278 [ Links ]

Kufa T, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant AD, et al. Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control. J Acquir Immune Defic Syndr. 2012;60(2):22-8. https://doi.org/10.1097/QAI.0b013e318251ae0b [ Links ]

Modi S, Cavanaugh JS, Shiraishi RW, Alexander HL, McCarthy KD, Burmen B, et al. Performance of clinical screening algorithms for tuberculosis intensified case finding among people living with HIV in Western Kenya. PLoS One. 2016;11(12):e0167685. https://doi.org/10.1371/journal.pone.0167685 [ Links ]

Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, Van Cutsem G, Goliath R, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis. 2012;55(12):1698-706. https://doi.org/10.1093/cid/cis775 [ Links ]

Swindells S, Komarow L, Tripathy S, Cain KP, MacGregor RR, Achkar JM, et al. Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253. Int J Tuberc Lung Dis. 2013;17(4):532-9. https://doi.org/10.5588/ijtld.12.0737 [ Links ]

Batista JDL, Albuquerque MFPM, Maruza M, Ximenes RAA, Santos ML, Montarroyos UR, et al. Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. PLoS One. 2013;8(5):e63916. https://doi.org/10.1371/journal.pone.0063916 [ Links ]

Camargo Jr KR, Coeli CM. Reclink: aplicativo para o relacionamento de bases de dados, implementando o método probabilistic record linkage. Cad Saude Publica. 2000;16(2):439-47. https://doi.org/10.1590/S0102-311X2000000200014 [ Links ]

Ministério da Saúde (BR), Secretaria de Vigilância em Saúde. Boletim Epidemiológico HIV/Aids 2016. Bol Epidemiol. 2017;48(1):1-52 [cited 2018 Jul 4]. Available from: http://portalarquivos2.saude.gov.br/images/pdf/2017/janeiro/05/2016_034-Aids_publicacao.pdf [ Links ]

Ministério da Saúde (BR), Conselho Nacional de Saúde. Resolução Nº 466, de 12 de dezembro de 2012. Resolve aprovar diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Brasília, DF: CNS; 2012 [cited 2017 Nov 14]. Available from: http://conselho.saude.gov.br/resolucoes/2012/reso466.pdf [ Links ]

Cohen GM, Drain PK, Noubary F, Cloete C, Bassett IV. Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa. J Acquir Immune Defic Syndr. 2014;67(3):e88-93. https://doi.org/10.1097/QAI.0000000000000309 [ Links ]

World Health Organization, Department of HIV/AIDS. Intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva (CH): WHO; 2011 [cited 2017 Nov 14]. Available from: https://www.who.int/hiv/pub/tb/9789241500708/en/ [ Links ]

Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. Manual de recomendações para o controle da tuberculose no Brasil. 2. ed atual. Brasília, DF; 2019. [ Links ]

World Health Organization. Global tuberculosis report 2018. Geneva (CH): WHO; 2018 [cited 2017 Nov 15]. Available from: https://apps.who.int/iris/handle/10665/274453 [ Links ]

Publicado

2021-07-23

Edição

Seção

Artigos Originais

Como Citar

Santos, M. L., Batista, J. d’Arc L., Braga, C., Silva, A. P. da ., Maruza, M., Souza, W. V., Carvalho, M. R. de ., Siqueira-Filha, N. T. de, & Albuquerque, M. de F. P. M. de. (2021). Effectiveness of screening for tuberculosis in HIV: a pragmatic clinical trial. Revista De Saúde Pública, 55, 45. https://doi.org/10.11606/s1518-8787.2021055002936

Dados de financiamento